3M's $10.3 Billion PFAS Settlement: What It Means for Individual Claims

When 3M announced a $10.3 billion PFAS settlement in June 2023, the headlines made it sound like a massive corporate reckoning. And in some ways it was. But the settlement had a specific scope that left out the people most obviously harmed: individuals who drank the contaminated water and developed cancer. Here's how the settlement actually works and what it means for personal injury plaintiffs.

The $10.3 Billion Settlement: What It Is

On June 22, 2023, 3M Company announced a settlement agreement in principle to resolve PFAS-related water contamination claims. The final settlement was approved by U.S. District Judge Richard Gergel in the District of South Carolina in May 2024.

The settlement amount: $10.3 billion, to be paid over 13 years (2024 through 2036), with an initial payment and annual installments. The amount adjusts based on the number of water systems that ultimately opt into the settlement and their documented contamination levels.

The defendant: 3M Company, the Minnesota-based conglomerate that manufactured PFOS and PFOA, the two PFAS compounds most widely implicated in water contamination. 3M was the primary manufacturer of these chemicals for decades, supplying them to manufacturers of AFFF firefighting foam, non-stick cookware coatings, stain-resistant fabric treatments, and hundreds of other products.

The plaintiffs: Public water utilities that sued 3M claiming PFAS contamination of their water sources required expensive treatment infrastructure. The settlement resolves those municipal claims.

Not included: Individual people.

Municipal Track vs. Personal Injury Track: Two Completely Different Lawsuits

The confusion about the 3M settlement often comes from a misunderstanding of who the plaintiffs were. PFAS litigation operates on two fundamentally different tracks:

Municipal/Water System Track: Cities, towns, counties, and water utilities sue PFAS manufacturers for the cost of contaminated source water. Their damages are infrastructure costs: installing filtration systems, testing water, notifying customers, and complying with new EPA regulations. These entities didn't get cancer. They got expensive engineering problems. The $10.3 billion 3M settlement, and DuPont's separate settlement package, resolve these municipal claims.

Personal Injury Track: Individual people who lived near contaminated water sources, worked with PFAS, or were otherwise exposed — and who developed cancer or other PFAS-linked health conditions — sue for personal damages: medical expenses, lost earnings, pain and suffering, and in some cases punitive damages. These claims are entirely separate from the municipal track and were explicitly excluded from the 3M settlement.

Why the distinction matters: the $10.3 billion is not being divided among cancer victims. It's earmarked for water treatment infrastructure. If you developed kidney cancer after years of drinking contaminated municipal water, your claim is not resolved by this settlement. It still exists. You just need to pursue it separately.

Why the $10.3B Doesn't Cover You

When 3M negotiated the settlement, it structured it deliberately to address the most pressing litigation risk it faced in the near term: the enormous cost-of-remediation claims by the thousands of water utilities that had been named plaintiffs in the MDL 2873 municipal litigation. These were cases with clear, documentable damages — the cost to install filtration systems — and with potentially unlimited exposure given the number of affected systems nationwide.

Personal injury claims were deliberately excluded. 3M's reasoning, consistent with what defendants always argue in staged settlements, is that: (1) personal injury causation is harder to prove; (2) the epidemiological science is still debated; (3) individual damages are more variable and harder to aggregate; and (4) a separate PI resolution process can be structured after the municipal wave is cleared.

Whether this strategy serves justice is another question entirely. Critics argue that the municipal settlement allows 3M to appear to have "resolved" its PFAS liability in the public eye while the people most directly harmed — those who got sick — are still waiting years for their day in court.

3M has not announced any global personal injury settlement as of April 2026. PI cases remain active in MDL 2873 and in state courts.

What Personal Injury PFAS Claims Look Like

A personal injury PFAS case requires establishing several elements:

Exposure: You must demonstrate that you were exposed to PFAS at significant levels over a meaningful period. This typically means documenting: your water source (municipal system with documented PFAS contamination, a private well near a contaminated site, or occupational PFAS exposure); the duration of your exposure; and, ideally, blood serum test results showing elevated PFAS body burden. Blood serum PFAS testing is available through commercial labs and provides direct evidence of internal exposure.

Injury: A diagnosed medical condition that the scientific evidence links to PFAS exposure. The strongest linkages, based on the epidemiological literature and the American Cancer Society's current guidance, are kidney cancer (renal cell carcinoma), testicular cancer, and thyroid disease. Bladder cancer and certain liver conditions are also emerging in the research. Some programs also include high cholesterol, ulcerative colitis, and reproductive complications.

Causation: Connecting your specific exposure to your specific diagnosis. This is where expert testimony becomes essential. Plaintiffs rely on epidemiologists and toxicologists who can testify that the type and level of your PFAS exposure is consistent with the type of cancer you developed.

Responsible party: Identifying which manufacturer or facility contaminated your source. This can be straightforward (you lived near a 3M plant) or complex (multiple industrial sources contributed to your water supply). AFFF-related cases in MDL 2873 often name multiple defendants, including 3M, DuPont/Chemours, Tyco Fire Products, and the companies that made or distributed specific AFFF products.

DuPont's Separate Settlement

3M wasn't the only major PFAS defendant. DuPont, which used PFOA extensively in manufacturing Teflon-coated products at its Washington Works plant in Parkersburg, West Virginia, was the subject of a separate settlement. DuPont and its spinoffs Chemours and Corteva agreed in July 2023 to pay up to $1.185 billion to settle water utility claims — also focused on municipal infrastructure, not individual injuries.

DuPont and Chemours have also faced personal injury claims from the Parkersburg community, the subject of a decade-long litigation that resulted in the "C8 Science Panel" findings establishing that PFOA causes several specific health conditions in the affected population. Those findings were used to compensate roughly 3,500 West Virginia residents in an earlier class settlement and remain foundational to the broader PFAS personal injury science.

For a broader overview of who the defendants are in PFAS litigation, see our 3M PFAS lawsuit page and our DuPont PFAS lawsuit page.

What to Do If You Have a PI Claim

If you lived in a PFAS-contaminated area and developed kidney cancer, testicular cancer, thyroid disease, or another PFAS-linked condition, here's the practical path:

Document your exposure history. Gather utility bills, lease agreements, or any records showing where you lived and for how long. Your state health department may have maps of known contaminated water systems. Use the EPA UCMR 5 database to document your water system's PFAS levels.

Get your medical records in order. Diagnosis date, treating physicians, pathology reports, and any prior screening history should be organized and ready to share with an attorney.

Consider a PFAS blood serum test. If you haven't been tested, a blood test showing elevated PFAS levels in your blood is strong supporting evidence for exposure. Several commercial labs offer this testing. Your doctor can order it.

Consult an attorney promptly. Statutes of limitations for PFAS personal injury cases vary by state, typically 2 to 3 years from when you knew or should have known the connection between your exposure and your diagnosis. Use our eligibility check to start the process.

For more on the AFFF-specific claims track, which involves its own MDL and different defendants, see our AFFF and military PFAS cancer overview. And to understand your contamination level, check how to look up your water system's PFAS data.

Related Resources

• 3M PFAS Lawsuit: Full Overview
• PFAS Settlement Amounts and Ranges
• PFAS Health Effects: Cancer and Other Conditions
• Check Your City's PFAS Contamination Level
• AFFF and Military PFAS Cancer Claims

Frequently Asked Questions